Both in Pharmaceuticals
Verrica Pharmaceuticals vs RenovoRx
Over the past year VRCA returned −7.6% and RNXT returned +18.3%; their daily moves had a correlation of 0.07.
VRCA −7.6% RNXT +18.3%Growth of $1, one year, split-adjusted
| Metric | VRCA | RNXT |
|---|---|---|
| Price | $3.29 | $1.29 |
| Market cap | $56.5M | $58.2M |
| Today | +2.49% | +2.38% |
| 1 month | −23.7% | −12.2% |
| 6 months | −54.1% | +39.0% |
| Year to date | −60.4% | +53.6% |
| 1 year | −8.9% | +16.2% |
| Revenue growth (YoY) | −53.8% | +115.4% |
| Gross margin | 85.0% | 84.3% |
| Net margin | −224.4% | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 29.5× |
| Net cash | $9.8M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 108.4% |
| Short % of float | 2.5% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).